Important Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds AbbVie, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit Pharmaceutical Investing
CLASS ACTION UPDATE for ABBV, AUPH and LICY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
Bausch + Lomb Presents Data from Second Pivotal Phase 3 Trial of Investigational Treatment NOV03 at the Association for Research in Vision and Ophthalmology Annual Meeting Pharmaceutical Investing
AUPH ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 14, 2022 in the Class Action Filed on Behalf of Aurinia Pharmaceuticals Inc. Limited Shareholders Pharmaceutical Investing
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Playstudios, Twitter, Aurinia, and Stronghold and Encourages Investors to Contact the Firm Pharmaceutical Investing
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Volta, Embark, Lucid, and AbbVie and Encourages Investors to Contact the Firm Pharmaceutical Investing
Aurinia Pharmaceuticals Inc. CLASS ACTION Alert: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Aurinia Pharmaceuticals Inc. Pharmaceutical Investing
Johnson & Johnson to Participate in the Bernstein 38th Annual Strategic Decisions Conference Pharmaceutical Investing
CLASS ACTION UPDATE for ABBV, MYPS and CS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
Aurinia Pharmaceuticals to Release First Quarter 2022 Financial and Operational Results on May 10, 2022 Pharmaceutical Investing
Rosen, A LEADING LAW FIRM, Encourages AbbVie Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - ABBV Pharmaceutical Investing
Seegnal Inc. Establishes Strategic Commercialization Team and Appoints Arx as Investor Relations Advisor
